These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 18775471)
21. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model. Julian LD; Wang Z; Bostick T; Caille S; Choi R; DeGraffenreid M; Di Y; He X; Hungate RW; Jaen JC; Liu J; Monshouwer M; McMinn D; Rew Y; Sudom A; Sun D; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP J Med Chem; 2008 Jul; 51(13):3953-60. PubMed ID: 18553955 [TBL] [Abstract][Full Text] [Related]
23. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid. Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019 [TBL] [Abstract][Full Text] [Related]
25. Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors. Su X; Halem HA; Thomas MP; Moutrille C; Culler MD; Vicker N; Potter BV Bioorg Med Chem; 2012 Nov; 20(21):6394-402. PubMed ID: 23040895 [TBL] [Abstract][Full Text] [Related]
26. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. Draper N; Stewart PM J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253 [TBL] [Abstract][Full Text] [Related]
27. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents. Boyle CD; Kowalski TJ Expert Opin Ther Pat; 2009 Jun; 19(6):801-25. PubMed ID: 19456274 [TBL] [Abstract][Full Text] [Related]
28. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors. Cho YS; Kim CH; Cheon HG Anal Biochem; 2009 Sep; 392(2):110-6. PubMed ID: 19497289 [TBL] [Abstract][Full Text] [Related]
30. Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold. Lepifre F; Christmann-Franck S; Roche D; Leriche C; Carniato D; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E Bioorg Med Chem Lett; 2009 Jul; 19(13):3682-5. PubMed ID: 19450980 [TBL] [Abstract][Full Text] [Related]
31. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase. Tomlinson JW; Stewart PM Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811 [TBL] [Abstract][Full Text] [Related]
32. Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1. Xia G; Liu L; Xue M; Liu H; Yu J; Li P; Chen Q; Xiong B; Liu X; Shen J Mol Cell Endocrinol; 2012 Jul; 358(1):46-52. PubMed ID: 22410288 [TBL] [Abstract][Full Text] [Related]
33. Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1. Tice CM; Zhao W; Krosky PM; Kruk BA; Berbaum J; Johnson JA; Bukhtiyarov Y; Panemangalore R; Scott BB; Zhao Y; Bruno JG; Howard L; Togias J; Ye YJ; Singh SB; McKeever BM; Lindblom PR; Guo J; Guo R; Nar H; Schuler-Metz A; Gregg RE; Leftheris K; Harrison RK; McGeehan GM; Zhuang L; Claremon DA Bioorg Med Chem Lett; 2010 Nov; 20(22):6725-9. PubMed ID: 20864344 [TBL] [Abstract][Full Text] [Related]
34. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes. Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614 [TBL] [Abstract][Full Text] [Related]
36. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors. Lee JH; Kang NS; Yoo SE Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331 [TBL] [Abstract][Full Text] [Related]
37. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. Hermanowski-Vosatka A; Balkovec JM; Cheng K; Chen HY; Hernandez M; Koo GC; Le Grand CB; Li Z; Metzger JM; Mundt SS; Noonan H; Nunes CN; Olson SH; Pikounis B; Ren N; Robertson N; Schaeffer JM; Shah K; Springer MS; Strack AM; Strowski M; Wu K; Wu T; Xiao J; Zhang BB; Wright SD; Thieringer R J Exp Med; 2005 Aug; 202(4):517-27. PubMed ID: 16103409 [TBL] [Abstract][Full Text] [Related]
38. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176 [TBL] [Abstract][Full Text] [Related]
39. Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Olson S; Aster SD; Brown K; Carbin L; Graham DW; Hermanowski-Vosatka A; LeGrand CB; Mundt SS; Robbins MA; Schaeffer JM; Slossberg LH; Szymonifka MJ; Thieringer R; Wright SD; Balkovec JM Bioorg Med Chem Lett; 2005 Oct; 15(19):4359-62. PubMed ID: 16039856 [TBL] [Abstract][Full Text] [Related]
40. Piperazine sulfonamides as potent, selective, and orally available 11beta-hydroxysteroid dehydrogenase type 1 inhibitors with efficacy in the rat cortisone-induced hyperinsulinemia model. Xiang J; Wan ZK; Li HQ; Ipek M; Binnun E; Nunez J; Chen L; McKew JC; Mansour TS; Xu X; Suri V; Tam M; Xing Y; Li X; Hahm S; Tobin J; Saiah E J Med Chem; 2008 Jul; 51(14):4068-71. PubMed ID: 18578516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]